Hod. Critchley et al., Regulation of bcl-2 gene family members in human endometrium by antiprogestin administration in vivo, J REPR FERT, 115(2), 1999, pp. 389-395
It is likely that the changes which occur in the endometrium throughout the
menstrual cycle involve apoptosis, and that expression of associated genes
, such as the bcl-2 family, are regulated by sex steroids. The aim of this
study was to investigate the presence of bcl-2, Bar and oestrogen receptor
proteins in secretory endometrium collected from ten patients with normal o
vulatory cycles 4 or 6 days after the LH surge, and on the same days in a s
ubsequent cycle in which the formation of secretory changes was inhibited b
y the administration of the antiprogestin mifepristone (RU486) 2 days after
the onset of the LH surge. Since some stromal cells display positive immun
oreactivity, leucocyte subpopulations of macrophages (CD68-positive) and la
rge granular lymphocytes (CD56-positive) were identified in serial sections
. After administration of mifepristone on day 2 after the LH surge, a signi
ficant increase in bcl2 immunoreactivity was observed in glandular and surf
ace epithelium. A positive correlation (0.874) with nuclear oestrogen recep
tor immunoreactivity in endometrial glands was demonstrated. Subsets of str
omal cells, identified as CD68-positive macrophages and CD56-positive large
granular lymphocytes displayed positive immunoreactivity for the bcl-2 epi
tope, which was unaffected by mifepristone administration. Bar immunostaini
ng was similar in control and antiprogestin-treated endometrium. These data
indicate that antiprogestin administration inhibits progesterone downregul
ation of steroid receptors in endometrial glands, resulting in persistence
of a proliferative endometrium and accompanying bcl-2 secretion.